WestEnd Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
OAG
PCM
WestEnd Advisors's CELG Position: Q1 2019 in Review
WestEnd Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 3 shares — an estimated $192 sold.
WestEnd Advisors first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $118M in Q4 2014. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.
- WestEnd Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
- WestEnd Advisors sold 3 Celgene Corp shares in Q1 2019, an estimated $192.
- WestEnd Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
- WestEnd Advisors's Celgene Corp position peaked at $118M in Q4 2014.
- 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.
Based on WestEnd Advisors's 13F filing for Q1 2019, filed 3 May 2019.